NMPA Suspends GSK’s Avodart Amid Inspection Findings
The National Medical Products Administration (NMPA) has decided to suspend the import, sales, and use...
NMPA
China’s NMPA Issues New Drug Recall Management Measures
The National Medical Products Administration (NMPA) has released the “Drug Recall Management Measures,” which took...
Haisco Pharma’s Ciprofol Injection Gains NMPA Approval for Gynecology Use
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced receiving another marketing approval from...
CDE Releases Draft Guidelines for Extrapolating Adult Drug Data to Pediatric Use
The Center for Drug Evaluation (CDE) has released the “Guidelines on Quantitative Methodology for Extrapolating...
NMPA Introduces Electronic Certificates for Biologics and Narcotic Drugs
The National Medical Products Administration (NMPA) has released a notification regarding the initiation of electronic...
China’s NMPA Proposes Reforms to Enhance Radiopharmaceutical Review and Approval
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Opinions on Reforming...
China’s NMPA Releases 60th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 60th batch of reference drugs for...
Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion
Insight Lifetech Co., Ltd, a Shenzhen-based provider of cardiovascular precision intervention solutions, has reportedly secured...
China’s First Proton Therapy System Approved by NMPA
The National Medical Products Administration (NMPA) has approved the proton therapy system developed by Shanghai...
NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 58th batch of reference drugs for...
NMPA Issues Guidelines on Medical Device Grading Administration
The National Medical Products Administration (NMPA) has released a set of Guiding Opinions on “Medical...
NMPA Designates Shijiazhuang Airport as Drug Import Port for Narcotics, Psychotropics
China’s National Medical Products Administration (NMPA) has designated Shijiazhuang Airport in Hebei Province as an...
NMPA Releases 57th Batch of Reference Drugs for Generic Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 57th batch of reference drugs for...
NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status
The National Medical Products Administration (NMPA) announced that omeprazole enteric-coated tablets have been reclassified from...
NMPA Suspends UCB’s Keppra Over Labeling Issues, Prompting Recall
The National Medical Products Administration (NMPA) has suspended approval for UCB’s Keppra (levetiracetam) concentrated solution...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
Dongcheng Pharmaceutical Gets NMPA Green Light for PSMA PET Imaging Drug
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced it has received approval from...
InxMed Receives $10M Debt Financing from SPD Silicon Valley Bank to Advance FAK Inhibitor IN10018
China-based biotech firm InxMed (Nanjing) Co., Ltd announced it has received $10 million in debt...
Digital Precision Medicine Raises Hundreds of Millions in Series B Financing for Molecular Imaging Innovation
China-based Digital Precision Medicine (DPM), a molecular imaging and fluorescence endoscopy manufacturer, has reportedly raised...
NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions
China’s National Medical Products Administration (NMPA) announced that potassium glucosamine sulfate has been reclassified from...